Department of Pharmacology, College of Pharmaceutical Science, Soochow University, Suzhou, Jiangsu 215123, China.
Chin Med J (Engl). 2012 Aug;125(16):2908-13.
To provide a summary of the relationship between the eEF-2/eEF-2 kinase pathway and each phase of malignant neoplasms. The speci?c importance of this relationship in understanding and treating cancer was also explored.
The data used in this review were mainly obtained from the articles listed in HighWire and PubMed in English. The search terms were "eEF-2 kinase", "oncogenesis", and "tumor progression".
This review relates the observation that the overexpression of eEF-2 kinase is seen in cancer, and highlights that it has emerged as promoting the development of many malignant phenotypes when unregulated. This includes increasing the replicative potential of cells, angiogenesis, invasion and metastasis, and evasion of apoptosis.
eEF-2 kinase is a structurally and functionally unique protein kinase. The increased activity of this protein in cancer cells is a protective mechanism to allow tumor growth and evolution, and resist cell death through the eEF-2/eEF-2 kinase pathway, but it also makes a potential target for therapy.
eEF-2 kinase fills critical niches in the life of a cancer cell and the eEF-2/eEF-2 kinase pathway is a key biochemical sensor.
总结真核延伸因子 2(eEF-2)/eEF-2 激酶途径与恶性肿瘤各阶段的关系。还探讨了这种关系在理解和治疗癌症方面的特殊重要性。
本综述使用的资料主要来自英文高引文献数据库(HighWire)和 PubMed 数据库中的文章。检索词为“eEF-2 激酶”“肿瘤发生”和“肿瘤进展”。
本综述观察到 eEF-2 激酶在癌症中过度表达,并强调其在不受调控时促进多种恶性表型的发展,包括增加细胞的复制潜能、血管生成、侵袭和转移以及逃避细胞凋亡。
eEF-2 激酶是一种结构和功能独特的蛋白激酶。该蛋白在癌细胞中的活性增加是一种保护机制,可允许肿瘤生长和进化,并通过 eEF-2/eEF-2 激酶途径抵抗细胞死亡,但它也为治疗提供了潜在的靶点。
eEF-2 激酶填补了癌细胞生命中的关键空缺,eEF-2/eEF-2 激酶途径是一个关键的生化传感器。